drugset / Trial / NCT00110682

Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses

NCT00110682

Phase 4 Completed 60 enrolled Derm Research @ 888 Inc. 3M · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Study Aims: * To compare the long-term efficacy and safety of imiquimod versus vehicle used as an adjunct to cryotherapy. * To assess and compare the recurrence rate and time to recurrence of the 2 different treatment groups. Hypothesis: The imiquimod arm will produce a more prolonged clearing of Actinic Keratoses (AK) compared to the vehicle arm.

Timeline

Start
2005-04
Primary completion
2006-10
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Imiquimod Other / unclassified 5 % Topical